0069 Prognostic factors upa and PAI-1: Feasibility and validity of determination in clinical routine (English)
- New search for: Vetter, M.
- New search for: Lantzsch, T.
- New search for: Abraha-Spath, S.
- New search for: Bauerfeind, U.
- New search for: Geurts-Moespot, A.
- New search for: Grosse, R.
- New search for: Dittmer, J.
- New search for: Sweep, F.
- New search for: Schmitt, M.
- New search for: Harbeck, N.
- New search for: Vetter, M.
- New search for: Lantzsch, T.
- New search for: Abraha-Spath, S.
- New search for: Bauerfeind, U.
- New search for: Geurts-Moespot, A.
- New search for: Grosse, R.
- New search for: Dittmer, J.
- New search for: Sweep, F.
- New search for: Schmitt, M.
- New search for: Harbeck, N.
In:
BREAST -EDINBURGH-
;
18
;
S35
;
2009
-
ISSN:
- Article (Journal) / Print
-
Title:0069 Prognostic factors upa and PAI-1: Feasibility and validity of determination in clinical routine
-
Contributors:Vetter, M. ( author ) / Lantzsch, T. ( author ) / Abraha-Spath, S. ( author ) / Bauerfeind, U. ( author ) / Geurts-Moespot, A. ( author ) / Grosse, R. ( author ) / Dittmer, J. ( author ) / Sweep, F. ( author ) / Schmitt, M. ( author ) / Harbeck, N. ( author )
-
Published in:BREAST -EDINBURGH- ; 18 ; S35
-
Publisher:
- New search for: Elsevier Science B.V., Amsterdam
-
Publication date:2009-01-01
-
Size:S35
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 618.19
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 618.19 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 18
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Pharyngo-laryngeal discomfort after breast surgery: Comparison between orotracheal intubation and laryngeal maskParotto, M. / Micaglio, M. / Ori, C. / Trevisanuto, D. et al. | 2009
- 2
-
Adjuvant endocrine therapy for perimenopausal women with early breast cancerOrtmann, O. / Cufer, T. / Dixon, J. M. / Maass, N. / Marchetti, P. / Pagani, O. / Pronzato, P. / Semiglazov, V. / Spano, J. P. / Vrdoljak, E. et al. | 2009
- 8
-
Relationship between body mass index, waist circumference and waist to hip ratio and the steroid hormone receptor status in breast carcinoma of pre- and postmenopausal womenPinheiro, R. L. / Sarian, L. O. / Pinto-Neto, A. M. / Morais, S. / Costa-Paiva, L. et al. | 2009
- 13
-
Ultrasound guided percutaneous axillary lymph node core biopsy: How often is the sentinel lymph node being biopsied?Britton, P. D. / Provenzano, E. / Barter, S. / Gaskarth, M. / Goud, A. / Moyle, P. / Sinnatamby, R. / Wallis, M. / Benson, J. R. / Forouhi, P. et al. | 2009
- 17
-
Immuno-modulatory effects of relaxation training and guided imagery in women with locally advanced breast cancer undergoing multimodality therapy: A randomised controlled trialEremin, O. / Walker, M. B. / Simpson, E. / Heys, S. D. / Ah-See, A. K. / Hutcheon, A. W. / Ogston, K. N. / Sarkar, T. K. / Segar, A. / Walker, L. G. et al. | 2009
- 26
-
Serum levels of angiogenic factors in early breast cancer remain close to normalDuranyildiz, D. / Camlica, H. / Soydinc, H. O. / Derin, D. / Yasasever, V. et al. | 2009
- 30
-
The prone technique for breast irradiation - is it ready for clinical trials?McKinnon, R. / Christie, D. / Peres, H. / Burke, M. / Le, T. / Lah, M. et al. | 2009
- 35
-
Mammographic density estimation: Comparison among BI-RADS categories, a semi-automated software and a fully automated oneTagliafico, A. / Tagliafico, G. / Tosto, S. / Chiesa, F. / Martinoli, C. / Derchi, L. E. / Calabrese, M. et al. | 2009
- 41
-
Tumour location is not an independent prognostic factor for survival following a diagnosis of breast cancerJayasinghe, U. W. / Boyages, J. et al. | 2009
- 47
-
Immediate reconstruction following breast-conserving surgery: Management of the positive surgical margins and influence on secondary reconstructionMunhoz, A. M. / Montag, E. / Arruda, E. / Aldrighi, C. M. / Filassi, J. R. / Piato, J. R. / Prado, L. C. / Aldrighi, J. M. / Gemperli, R. / Ferreira, M. C. et al. | 2009
- 55
-
Analysis of RhoC expression and lymphovascular emboli in inflammatory vs non-inflammatory breast cancers in Egyptian patientsLo, A. C. / Georgopoulos, A. / Kleer, C. G. / Banerjee, M. / Omar, S. / Khaled, H. / Eissa, S. / Hablas, A. / Omar, H. G. / Douglas, J. A. et al. | 2009
- 60
-
Aesthetic and functional correction of female, asymmetric funnel chest - A combined approachBeier, J. P. / Weber, P. G. / Reingruber, B. / Huemmer, H. P. / Kneser, U. / Dragu, A. / Horch, R. E. / Bach, A. D. et al. | 2009
- 66
-
Modified resistance to chemotherapy and trastuzumab by bevacizumab in locally recurrent breast cancerFarhat, M. H. / El-Saghir, N. S. / Shamseddine, A. I. et al. | 2009
- 69
-
Preservation of the lateral thoracic vein in axillary dissection - Its role in breast reconstruction using the DIEP flapChand, M. / Swan, M. C. / Horlock, N. / Royle, G. et al. | 2009
- 71
-
Health economic decision making in Europe - a new priority for breast cancer advocacyKnox, S. et al. | 2009
- 73
-
Ultrasound-guided vacuum assisted breast biopsy in the assessment of C3 breast lesions by ultrasound-guided fine needle aspiration cytology: Results and costs in comparison with surgeryAbbate, F. / Bacigalupo, L. / Latronico, A. / Trentin, C. / Penco, S. / Menna, S. / Viale, G. / Cassano, E. / Bellomi, M. et al. | 2009
- 78
-
Initial treatment and changes in adjuvant endocrine therapy for early stage breast cancerSchwartzberg, L. S. / Cobb, P. / Senecal, F. / Henry, D. / Kulig, K. / Walker, M. S. / Houts, A. C. / Stepanski, E. J. et al. | 2009
- 84
-
Bone Quality Test (BQT) scores of fingernails in postmenopausal patients treated with adjuvant letrozole or tamoxifen for early breast cancerSun, Z. / Goldhirsch, A. / Price, K. N. / Colleoni, M. / Ravaioli, A. / Simoncini, E. / Campbell, I. / Gelber, R. D. / Towler, M. et al. | 2009
- 89
-
Perceptions of ductal carcinoma in situ (DCIS) among UK health professionalsKennedy, F. / Harcourt, D. / Rumsey, N. et al. | 2009
- 94
-
Chest wall resection for internal mammary lymph node metastases of breast cancervan Geel, A. N. / Wouters, M. W. / van der Pol, C. / Schmitz, P. I. / Lans, T. et al. | 2009
- 100
-
Patient-led breast cancer follow upChapman, D. / Cox, E. / Britton, P. D. / Wishart, G. C. et al. | 2009
- 103
-
Predicting the status of axillary lymph nodes in breast cancer: A multiparameter approach including axillary ultrasound scanningSusini, T. / Nori, J. / Olivieri, S. / Molino, C. / Marini, G. / Bianchi, S. / Vezzosi, V. / Livi, L. / Mascalchi, M. / Scarselli, G. et al. | 2009
- 109
-
Volume-controlled vs no/short-term drainage after axillary lymph node dissection in breast cancer surgery: A meta-analysisDroeser, R. A. / Frey, D. M. / Oertli, D. / Kopelman, D. / Baas-Vrancken Peeters, M. J. / Giuliano, A. E. / Dalberg, K. / Kallam, R. / Nordmann, A. et al. | 2009
- 115
-
Pectoralis major interposition flap: A new technique for treatment of severe peri-ductal mastitisLow, N. / Barry, P. A. et al. | 2009
- 119
-
High-resolution ultrasonographic features of axillary lymph node metastasis in patients with breast cancerChoi, Y. J. / Ko, E. Y. / Han, B. K. / Shin, J. H. / Kang, S. S. / Hahn, S. Y. et al. | 2009
- 123
-
A new radiological approach to cyclic mastalgia: Venous doppler ultrasoundYakut, Z. I. / Kafali, H. / Karaoglanoglu, M. / Koktener, A. / Duvan, C. i. et al. | 2009
- 126
-
Immediate reconstruction using thoracodorsal adipofascial flap after partial mastectomyKijima, Y. / Yoshinaka, H. / Funasako, Y. / Kaneko, K. / Hirata, M. / Ishigami, S. / Natsugoe, S. et al. | 2009
- 130
-
Feasibility study on radiofrequency ablation followed by partial mastectomy for stage I breast cancer patientsImoto, S. / Wada, N. / Sakemura, N. / Hasebe, T. / Murata, Y. et al. | 2009
- 135
-
Ki-67 as a prognostic molecular marker in routine clinical use in breast cancer patientsWiesner, F. G. / Magener, A. / Fasching, P. A. / Wesse, J. / Bani, M. R. / Rauh, C. / Jud, S. / Schrauder, M. / Loehberg, C. R. / Beckmann, M. W. et al. | 2009
- 142
-
Corrigendum to "Vascular endothelial growth factor is a strong predictor of early distant recurrences in a prospective study of premenopausal women with lymph-node negative breast cancer" [The Breast 17 (2008) 484-491]Linderholm, B. K. / Gruvberger-Saal, S. / Ferno, M. / Bendahl, P. O. / Malmstrom, P. et al. | 2009
- 143
-
Post-operative radiotherapy for ductal carcinoma in situ of the breast - A systematic review of the randomised trialsGoodwin, A. / Parker, S. / Ghersi, D. / Wilcken, N. et al. | 2009
- 150
-
Endoscopic axillary dissection: A systematic review of the literatureAponte-Rueda, M. E. / Saade Cardenas, R. A. / Saade Aure, M. J. et al. | 2009
- 159
-
The effect of exemestane or tamoxifen on markers of bone turnover: Results of a German sub-study of the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trialHadji, P. / Ziller, M. / Kieback, D. G. / Menschik, T. / Kalder, M. / Kuck, J. / Hasenburg, A. et al. | 2009
- 165
-
Phyllodes tumours of the breast: A clinicopathological analysis of 65 cases from a single institutionKarim, R. Z. / Gerega, S. K. / Yang, Y. H. / Spillane, A. / Carmalt, H. / Scolyer, R. A. / Lee, C. S. et al. | 2009
- 171
-
21-Gene expression profile assay on core needle biopsies predicts responses to neoadjuvant endocrine therapy in breast cancer patientsAkashi-Tanaka, S. / Shimizu, C. / Ando, M. / Shibata, T. / Katsumata, N. / Kouno, T. / Terada, K. / Shien, T. / Yoshida, M. / Hojo, T. et al. | 2009
- 175
-
The role of freehand needle core biopsy in the diagnosis of isolated axillary lymphadenopathyNair, A. / Jaleel, S. / Sathya, V. / Daultrey, C. / Aluwihare, N. / Isgar, B. et al. | 2009
- 178
-
Accuracy of stereotactic vacuum-assisted breast biopsy with a 10-gauge hand-held systemSalem, C. / Sakr, R. / Chopier, J. / Marsault, C. / Uzan, S. / Darai, E. et al. | 2009
- 183
-
XRCC1 gene polymorphisms and breast cancer risk in different populations: A meta-analysisLi, H. / Ha, T. C. / Tai, B. C. et al. | 2009
- 192
-
An evaluation of a 10-gauge vacuum-assisted system for ultrasound-guided excision of clinically benign breast lesionsWang, Z. L. / Li, J. L. / Su, L. / Zhang, Y. F. / Tang, J. et al. | 2009
- 197
-
NOEY2 mutations in primary breast cancers and breast hyperplasiaYang, J. / Hu, A. / Wang, L. / Li, B. / Chen, Y. / Zhao, W. / Xu, W. / Li, T. et al. | 2009
- 204
-
Bone turnover markers in postmenopausal breast cancer treated with fulvestrant - A pilot studyAgrawal, A. / Hannon, R. A. / Cheung, K. L. / Eastell, R. / Robertson, J. F. et al. | 2009
- 208
-
Quality of mammography screening in the Milan programme: Evidence of improved sensitivity based on interval cancer proportional incidence and radiological reviewElena, P. M. / Nehmat, H. / Ermes, M. / Piera, C. / Maria, Q. / Guia, M. / Francesco, C. / Roberto, V. / Giovanni, F. / Isabella, G. et al. | 2009
- 211
-
Sunitinib in breast cancer: Friend or foeCardoso, F. / Senkus-Konefka, E. et al. | 2009
- 213
-
Bisphosphonate-associated osteonecrosis of the jaw in breast cancer patients: Recommendations for prevention and treatmentFehm, T. / Felsenberg, D. / Krimmel, M. / Solomayer, E. / Wallwiener, D. / Hadjii, P. et al. | 2009
- 218
-
Improving the therapeutic index of anthracycline chemotherapy: Focus on liposomal doxorubicin (Myocet)Leonard, R. C. / Williams, S. / Tulpule, A. / Levine, A. M. / Oliveros, S. et al. | 2009
- 225
-
Axillary metastatic disease as presentation of occult or contralateral breast cancerLanitis, S. / Behranwala, K. A. / Al-Mufti, R. / Hadjiminas, D. et al. | 2009
- 228
-
Survivin and COX-2 expression in male breast carcinomaYounis, T. / Hache, K. D. / Rayson, D. / Dewar, R. / Gray, S. / Barnes, P. J. et al. | 2009
- 233
-
Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancerVoguet, L. / Hebert, T. / Leveque, J. / Acker, O. / Mesbah, H. / Marret, H. / Poree, P. / Body, G. et al. | 2009
- 238
-
Ipsilateral breast tumor relapse after breast conserving surgery in women with breast cancerYoshida, T. / Takei, H. / Kurosumi, M. / Ninomiya, J. / Ishikawa, Y. / Hayashi, Y. / Tozuka, K. / Oba, H. / Inoue, K. / Tabei, T. et al. | 2009
- 244
-
Positive sentinel lymph node biopsy predicts the number of metastatic axillary nodes of breast cancerTakei, H. / Kurosumi, M. / Yoshida, T. / Ninomiya, J. / Ishikawa, Y. / Hayashi, Y. / Tozuka, K. / Asakawa, H. / Oba, H. / Inoue, K. et al. | 2009
- 248
-
Intra-operative touch preparation cytology following lumpectomy for breast cancer: A series of 400 proceduresDHalluin, F. / Tas, P. / Rouquette, S. / Bendavid, C. / Foucher, F. / Meshba, H. / Blanchot, J. / Coue, O. / Leveque, J. et al. | 2009
- 254
-
Results of tailored treatment for breast cancer patients with internal mammary lymph node metastasesHeuts, E. M. / van der Ent, F. W. / Hulsewe, K. W. / von Meyenfeldt, M. F. / Voogd, A. C. et al. | 2009
- 259
-
Early experience with sunitinib, combined with docetaxel, in patients with metastatic breast cancerLiljegren, A. / Bergh, J. / Castany, R. et al. | 2009
- 263
-
Outcome of T1N0M0 breast cancer in relation to St. Gallen risk assignment criteria for adjuvant therapyGarassino, I. / Gullo, G. / Orefice, S. / Tondulli, L. / Masci, G. / Salvini, P. / Eboli, M. / Di Tommaso, L. / Giordano, L. / Alloisio, M. et al. | 2009
- 267
-
Localization of impalpable breast lesions: What are we aiming at?Mucci, B. / Shaw, R. / Lauder, J. / Pickard, R. et al. | 2009
- 271
-
Metastatic breast cancer patients: The forgotten heroes!Cardoso, F. et al. | 2009
- 273
-
Bridging Gaps, Expanding Outreach: Metastatic Breast Cancer Advocacy Working Group Consensus ReportMBC, A. W. et al. | 2009
- 276
-
Safety and efficacy of contra-lateral breast reduction for women with mammary hypertrophy undergoing mastectomy for breast cancerGreen, M. / Aspinall, S. / Kollias, J. et al. | 2009
- 279
-
Hearing sensitivity in women following chemotherapy treatment for breast cancer: Results from a pilot studyJenkins, V. / Low, R. / Mitra, S. et al. | 2009
- 284
-
Comparison of interval breast cancer rates for two-versus single-view screening mammography: A population-based studySeigneurin, A. / Exbrayat, C. / Labarere, J. / Colonna, M. et al. | 2009
- 289
-
Chemoprevention Indication Score: A user-friendly tool for prevention of breast cancer - Pilot analysisLayeequr Rahman, R. / Crawford, S. et al. | 2009
- 294
-
Factors correlated to successful surgical treatment of 181 non-palpable invasive breast carcinomasBesic, N. / Kramaric, A. / Podnar, B. / Perhavec, A. / Music, M. / Grazio-Frkovic, S. / Zgajnar, J. et al. | 2009
- 299
-
Breast cancer in the Thai Cohort Study: An exploratory case-control analysisJordan, S. / Lim, L. / Vilainerun, D. / Banks, E. / Sripaiboonkij, N. / Seubsman, S. a. / Sleigh, A. / Bain, C. et al. | 2009
- 304
-
Ovarian ablation by radiation therapy: Is it still an option for the ablation of ovarian function in endocrine responsive premenopausal breast cancer patients?Bese, N. S. / Iribas, A. / Dirican, A. / Oksuz, D. / Atkovar, G. / Ober, A. et al. | 2009
- 309
-
Efficient reduction of loco-regional recurrences but no effect on mortality twenty years after postmastectomy radiation in premenopausal women with stage II breast cancer - A randomized trial from the South Sweden Breast Cancer GroupKillander, F. / Anderson, H. / Ryden, S. / Moller, T. / Hafstrom, L. O. / Malmstrom, P. et al. | 2009
- 316
-
Stage I breast cancer in a regional oncology practice in Israel 2002-2006: Clinicopathologic features, risk estimation and planned therapy of 328 consecutive patientsGeffen, D. B. / Amir, N. / Sion-Vardy, N. / Ariad, S. / Kachko, L. / Bayme, M. / Delgado, B. / Dyomin, V. / Argov, S. / Koretz, M. et al. | 2009
- 322
-
Reoperative sentinel lymph node biopsy in ipsilateral breast cancer relapseTasevski, R. / Gogos, A. J. / Mann, G. B. et al. | 2009
- 327
-
Long-term follow-up-findings in mammography and ultrasound after intraoperative radiotherapy (IORT) for breast cancerRuch, M. / Brade, J. / Schoeber, C. / Kraus-Tiefenbacher, U. / Schnitzer, A. / Engel, D. / Wenz, F. / Sutterlin, M. / Schoenberg, S. O. / Wasser, K. et al. | 2009
- 335
-
Bisphosphonate osteonecrosis of the jaws in cancer patientsKyrgidis, A. / Andreadis, C. et al. | 2009
- 337
-
Pregnancy in breast cancer survivors: A need for proper counselingPeccatori, F. A. / Azim, H. A. et al. | 2009
- 339
-
Neoadjuvant endocrine treatment in primary breast cancer - Review of literatureMathew, J. / Asgeirsson, K. S. / Jackson, L. R. / Cheung, K. L. / Robertson, J. F. et al. | 2009
- 345
-
Pregnancy after breast cancer: The importance of active counselling and planningRippy, E. E. / Karat, I. F. / Kissin, M. W. et al. | 2009
- 351
-
The prognostic significance of single hormone receptor positive metastatic breast cancer: An analysis of three randomised phase III trials of aromatase inhibitorsStuart-Harris, R. / Shadbolt, B. / Palmqvist, C. / Chaudri Ross, H. A. et al. | 2009
- 356
-
Optimizing the nipple-areola sparing mastectomy with double concentric periareolar incision and biodimensional expander-implant reconstruction: Aesthetic and technical refinementsMunhoz, A. M. / Aldrighi, C. / Montag, E. / Arruda, E. / Aldrighi, J. M. / Filassi, J. R. / Ricci, M. / Brasil, J. A. / Rezende, V. / Ferreira, M. C. et al. | 2009
- 368
-
Debating the mathematical model to validate the sentinel lymph biopsy techniques in breast cancer patients. The danger of bias and its practical implicationsMartinez-Ramos, D. / Escrig-Sos, J. / Alcalde-Sanchez, M. / Hoashi, J. S. / Salvador-Sanchis, J. L. et al. | 2009
- 373
-
Conservative surgery with and without radiotherapy in elderly patients with early-stage breast cancer: A prospective randomised multicentre trialTinterri, C. / Gatzemeier, W. / Zanini, V. / Regolo, L. / Pedrazzoli, C. / Rondini, E. / Amanti, C. / Gentile, G. / Taffurelli, M. / Fenaroli, P. et al. | 2009
- 378
-
Are males with early breast cancer treated differently from females with early breast cancer in Australia and New Zealand?Wang, J. / Kollias, J. / Marsh, C. / Maddern, G. et al. | 2009
- 382
-
Association between mode of breast cancer detection and diagnosis delayCrispo, A. / Montella, M. / Barba, M. / Schittulli, F. / De Marco, M. R. / Grimaldi, M. / Quaranta, M. / Serravezza, G. / Savastano, C. / Botti, G. et al. | 2009
- 387
-
Intramammarian flap reconstruction (IFR) technique in breast conserving surgeryRageth, C. J. / Tausch, C. et al. | 2009
- I
-
Acknowledgement to Reviewers| 2009
- S1
-
Clinical perspectives on the utility of aromatase inhibitors for the adjuvant treatment of breast cancerChlebowski, R. / Cuzick, J. / Amakye, D. / Bauerfeind, I. / Buzdar, A. / Chia, S. / Cutuli, B. / Linforth, R. / Maass, N. / Noguchi, S. et al. | 2009
- S1
-
S3 The changes in breast cancer incidence: A result of recent changes in hormone use by postmenopausal women?Ravdin, P. M. et al. | 2009
- S2
-
Facilitating consensus by examining patterns of treatment effectsGelber, R. D. / Gelber, S. et al. | 2009
- S2
-
S5 Aiming at the target: In the crosshairs or the crossfire?Piccart-Gebhart, M. / Bedard, P. L. / Dinh, P. et al. | 2009
- S3
-
S8 Integrating molecular profiling, histologic type and other variables: Defining the fingerprint of responsiveness to treatmentViale, G. et al. | 2009
- S4
-
S10 Chemoprevention of breast cancer for mutation carriers and other high risk womenDecensi, A. / Puntoni, M. et al. | 2009
- S6
-
S15 The (last?) word about biomarkers for angiogenesisBertolini, F. / Mancuso, P. / Curigliano, G. / Nole, F. / Torrisi, R. / Colleoni, M. / Goldhirsch, A. et al. | 2009
- S7
-
S17 Breast cancer stem cells: Getting to treat the coreWicha, M. S. / Ginestier, C. / Dontu, G. / Liu, S. / Clouthier, S. / Charaafe-Jauffret, E. et al. | 2009
- S8
-
S21 Molecular imaging of breast cancerde Vries, E. / Oude Munnink, T. / Nagengast, W. / Brouwers, A. / Schroder, C. / Hospers, G. / Lub-de Hooge, M. / van der Wall, E. / van Diest, P. et al. | 2009
- S9
-
S23 Update of the BIG 1-98 Trial: Where do we stand? Sequential treatment analysis and monotherapy arm analysisThurlimann, B. et al. | 2009
- S10
-
New hypotheses and opportunities in endocrine therapy: amplification of oestrogen-induced apoptosisJordan, V. C. / Lewis-Wambi, J. S. / Patel, R. R. / Kim, H. / Ariazi, E. A. et al. | 2009
- S11
-
S27 Breast conservation and sentinel lymph node biopsy after neoadjuvant systemic therapyVeronesi, P. / Rodriguez, J. et al. | 2009
- S12
-
S30 Should the use of contralateral prophylactic mastectomy be increasing as it is?Wood, W. C. et al. | 2009
- S13
-
S32 Innovations in radiation therapy (RT) for breast cancerHarris, J. et al. | 2009
- S14
-
S34 Targeting the tumour and sparing normal tissue: The concept behind the evolutionVeronesi, U. et al. | 2009
- S15
-
S37 Is there a standard type and duration of adjuvant chemotherapy?Hayes, D. et al. | 2009
- S16
-
S39 Treatment of postmenopausal women with hormone responsive breast cancerWiner, E. et al. | 2009
- S17
-
S43 Review of new targeted drugs: Crawling towards the adjuvant settingBaselga, J. et al. | 2009
- S18
-
Adjuvant chemotherapy - the dark side of clinical trials Have we learnt more?Oakman, C. / Pestrin, M. / Cantisani, E. / Licitra, S. / DeStefanis, M. / Biganzoli, L. / Di Leo, A. et al. | 2009
- S19
-
0004 DNA hypermethylation in breast cancer and its association with clinicopathological featuresChen, F. / Ou-Yang, F. / Yang, S. / Chang, S. / Hou, M. et al. | 2009
- S20
-
0008 Epigenetic field cancerization of MTHFR gene in breast carcinomasLee, J. / Kim, J. / Suh, K. / Oh, T. / An, S. / Choi, B. / Chang, E. et al. | 2009
- S21
-
0012 Presence of an in-situ component is associated with reduced biological aggressiveness of invasive breast cancer as assessed by Ki-67 indicesWong, H. / Lau, S. / Cheung, P. / Epstein, R. J. et al. | 2009
- S22
-
0016 The coamplification pattern of HER-2/NEU amplicon by real-time PCR in human breast cancer and its clinical significanceLim, W. / Ahn, S. / Noh, D. / Han, W. et al. | 2009
- S23
-
0022 Ultrasound-guided Mammotome biopsy for breast microcalcification using 2-dimensional mammography localizationYom, C. / Koo, M. / Moon, B. / Park, Y. et al. | 2009
- S25
-
0030 Dynamic magnetic resonance imaging predicts biological features of breast cancerSchneider, J. / Gonzalez-Lopez, A. / Martinez-Arribas, F. / Martin-Garabato, E. / Madrigal, J. et al. | 2009
- S25
-
Aiming at the target: improved adjuvant medical therapyBedard, P. L. / Dinh, P. / Sotiriou, C. / Piccart-Gebhart, M. J. et al. | 2009
- S27
-
0041 HER-2 codon 655 single nucleotide polymorphism and HER-2 protein expression in ductal breast cancerZubor, P. / Kajo, K. / Stanclova, A. / Dokus, K. / Fiolka, R. / Visnovsky, J. / Danko, J. et al. | 2009
- S28
-
0045 The significance of annexin A1 expression in breast cancerYom, C. / Moon, B. / Park, Y. / Koo, M. et al. | 2009
- S30
-
0052 Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patientsLin, Y. / Yin, W. / Zhou, L. / Lu, J. / Di, G. / Wu, J. / Shen, K. / Han, Q. / Shen, Z. / Shao, Z. et al. | 2009
- S32
-
0059 Oncotype Dx, St. Gallen risk group and Adjuvantlonline nomogram as prognostic predictorLeitzin, L. / Sikorsky, N. / Leviov, M. / Grikstass, E. / Steiner, M. et al. | 2009
- S32
-
Integrating molecular profiling, histological type and other variables: Defining the fingerprint of responsiveness to treatmentViale, G. et al. | 2009
- S34
-
0066 Tailored adjuvant therapy for young women with breast cancerYoshida, M. / Shimizu, C. / Kinoshita, T. / Fujiwara, Y. et al. | 2009
- S36
-
0073 The 70-gene MammaPrint signature is predictive for chemotherapy benefit in early breast cancerKnauer, M. / Straver, M. / Rutgers, E. / Bender, R. / Cardoso, F. / Mook, S. / van de Vijver, M. / Saghatchian, M. / Koornstra, R. / Bueno-de-Mesquita, J. et al. | 2009
- S37
-
0076 Delayed chemotherapy and/or dose reduction. A model to accurately predict the dose-intensityBanu, E. et al. | 2009
- S38
-
The biological information obtainable from circulating tumor cellsCristofanilli, M. et al. | 2009
- S39
-
0086 Selective axillary lymph node dissection differs from the arm lymph flow shown by 3D-CT lymphographyYamashita, K. / Shimizu, K. / Akasu, H. / Igarashi, T. / Jikuzono, T. / Hames, K. / Yanagihara, K. / Iida, S. / Haga, S. et al. | 2009
- S40
-
0089 Isolated tumor cells in the sentinel lymph node in breast cancer: Only a dimensional difference from micrometastases?Giorgetta, C. E. / Limonta, M. E. / Recalcati, S. / Tricomi, P. / Dainese, E. / Recalcati, A. et al. | 2009
- S41
-
Issues regarding improving the impact of antiangiogenic drugs for the treatment of breast cancerKerbel, R. S. et al. | 2009
- S42
-
0096 Usefulness of intraoperative histologic assessment of surgical marginsKikuyama, M. / Akashi-Tanaka, S. / Yoshida, M. / Hojo, T. / Kinoshita, T. / Iwamoto, E. / Tsuda, H. et al. | 2009
- S43
-
0100 Nipple-areola-sparing mastectomy: Over 10 years follow-upUmemura, T. / Sakurai, T. / Jinta, E. / Suzuma, T. / Yoshimura, G. / Juri, M. et al. | 2009
- S44
-
0103 Ductal breast carcinomas: Residual tumor rate in re-excisions after breast conserving surgerySancho Perez, B. / Sanz, C. / Noguero, R. / Gallego, M. / Arroyo, L. / Aragon, S. / Hernandez, J. M. et al. | 2009
- S46
-
0111 Soreness and sensitivity to sun exposure 10 to 16 years after breast cancer radiotherapy - a randomized studyLundstedt, D. / Gustafsson, M. / Malmstrom, P. / Olofsson, U. / Holmberg, E. / Anderson, H. / Steineck, G. / Karlsson, P. et al. | 2009
- S47
-
0114 Evaluation of the impact of postmastectomy adjuvant radiotherapy in patients with less than four axillary lymph nodes: A retrospective analysisGangopadhyay, A. / Saha, S. / Ghosh, K. et al. | 2009
- S48
-
Biomarkers for angiogenesis and antiangiogenic drugs in clinical oncologyBertolini, F. et al. | 2009
- S48
-
0118 A preliminary report of a phase I study of intraoperative radiotherapy (IORT) for early breast cancer in JapanSawaki, M. / Sato, S. / Kagawa, C. / Yamada, T. / Takada, H. / Kikumori, T. / Oda, K. / Ishihara, S. / Ito, Y. / Imai, T. et al. | 2009
- S51
-
0132 The effect of zoledronic acid in postmenopausal women (PMW) with early breast cancer (EBC) receiving adjuvant letrozole: 24 months integrated follow-up of the Z-FAST/ZO-FAST trialsFrassoldati, A. / Brufsky, A. / Bundred, N. / Lambert-Falls, R. / Hadji, P. / Schenk, N. / Paija, O. / Mena, R. / Coleman, R. et al. | 2009
- S51
-
Immunizing against breast cancer: A new swing for an old swordCurigliano, G. / Locatelli, M. / Fumagalli, L. / Goldhirsch, A. et al. | 2009
- S53
-
0140 Retrospective study for pegylated liposomal doxorubicin in adjuvant breast cancer therapyLu, Y. / Hsieh, C. / Hou, M. / Ou-Yang, F. / Chang, K. / Chen, D. / Wang, H. et al. | 2009
- S54
-
0143 First efficacy report for China TAX 619 study: Docetaxel in combination with anthracycline and cyclophosphamide or docetaxel followed by anthracycline and cyclophosphamide in adjuvant therapy for operable node positive breast cancerShen, Z. / Liu, G. / Shao, Z. / Wang, S. / Zhang, B. / Jiang, Z. / He, P. et al. | 2009
- S55
-
0146 Chronobiological rhythms of cytokines level of breast cancerMelnikov, D. Y. et al. | 2009
- S56
-
0149 Echocardiography is better than MUGA scan in some breast cancer patients to monitor LVEF for adjuvant trastuzumab therapyMoe, M. M. et al. | 2009
- S56
-
Targeting breast cancer stem cellsWicha, M. S. et al. | 2009
- S59
-
Pharmacogenetics of breast cancer therapiesHertz, D. L. / McLeod, H. L. / Hoskins, J. M. et al. | 2009
- S61
-
0173 Predictive value of 18F-FDG PET-CT in primary breast cancer patients receiving neoadjuvant chemotherapyTsang, J. W. / Yeung, D. / Chan, A. C. / Wong, C. H. / Leung, L. W. / Lo, C. S. / Fung, L. H. / Epstein, R. J. / Kwong, A. et al. | 2009
- S63
-
0180 Weekly paclitaxel plus carboplatin +/- trastuzumab in preoperative therapy of Her2-neu over-expressing breast cancer: A pilot phase II studyChen, X. / Chen, C. / Wu, J. / Lu, J. / Shao, Z. / Shen, Z. / Shen, K. et al. | 2009
- S64
-
0183 Progranulin (PC-derived growth factor) levels in serum do not predict response to neoadjuvant capecitabine (X), docetaxel (T) and trastuzumab (H) for patients (pts) with locally advanced breast cancer (LABC)Wildiers, H. / Buysschaert, I. / Van Hootegem, A. / Smeets, A. / Vanden Bempt, I. / Neven, P. / Moerman, P. / Schoffski, P. / Paridaens, R. / Lambrechts, D. et al. | 2009
- S66
-
Molecular imaging of breast cancerMunnink, T. H. / Nagengast, W. B. / Brouwers, A. H. / Schroder, C. P. / Hospers, G. A. / Hooge, M. N. / van der Wall, E. / van Diest, P. J. / de Vries, E. G. et al. | 2009
- S66
-
0191 Protection of ovarian function with an LH-RH analogue during chemotherapy in young breast cancer patientsOgawa, M. / Masuda, N. / Yamamura, J. / Masuda, H. / Karita, M. / Nakamori, S. / Tsujinaka, T. et al. | 2009
- S67
-
0194 Medical ozone oil suspension applications heal osteonecrosis of the jaws (ONJS) in patients treated with bisfosfonates (BPS). Preliminary results of a single institution protocolRipamonti, C. / Maniezzo, M. / Ghiringhelli, R. / Fagnoni, E. / Campa, T. / Mariani, L. / Cislaghi, E. et al. | 2009
- S69
-
0201 Evidence-based recommendation for discussing complementary and alternative therapy use with cancer patientsSchofield, P. E. / Diggens, J. / Marigliani, R. X. / Jefford, M. et al. | 2009
- S72
-
0217 Differences in outcome of young breast cancer patients according to BRCA1 mutation statusGabrys, D. / Trela, K. / Boratyn-Nowicka, A. / Suwinski, R. / Grzybowska, E. / Behrendt, K. / Galwas-Kliber, K. / Wojcieszek, P. / Idasiak, A. / Pekala, W. et al. | 2009
- S73
-
0221 Locally advanced breast cancer in Asian womenLee, J. / Chong, C. / Seah, J. / Tan, S. et al. | 2009
- S74
-
The follow-up of women at high risk for breast cancer relapseSmith, I. E. / Banerjee, S. et al. | 2009
- S74
-
0225 Breast carcinoma in Jewish and non-Jewish populationRabkin, A. / Shklar, Z. / Sinatzky, K. / Rubinov, R. / Keren, S. / Leviov, M. / Mariana, S. et al. | 2009
- S75
-
0228 Multicentre investigation of HER2 expression in 1806 infiltrating carcinomas of the breast in the Chinese populationLu, Z. / Chen, D. / Zheng, J. / Da, J. / Zhu, M. / Li, Q. / Lang, R. / Sun, W. / Zhou, X. / Liu, Y. et al. | 2009
- S77
-
0236 Clinicopathologic features of microinvasive cancer compared with DCISMin, S. / Jung, S. / Kim, H. / Lee, S. / Kim, S. / Kwon, Y. / Shin, K. / Kang, H. et al. | 2009
- S78
-
0243 Trends of adjuvant systemic therapy of breast cancer in Grodno region (Belarus)Kazakevich, D. / Yakovets, A. / Polubiatko, T. / Myshko, I. / Solodovnikov, A. / Sergej, V. / Rum, E. / Vdovichenko, V. et al. | 2009
- S78
-
Update of the BIG 1-98 Trial: Where do we stand?Joerger, M. / Thurlimann, B. et al. | 2009
- S79
-
0247 Breast cancer in Kenyan womenNyabade, G. O. et al. | 2009
- S81
-
Author Index| 2009
- S84
-
Breast conservation and negative margins: how much is enough?Morrow, M. et al. | 2009
- S87
-
Breast conservation for the very young?Rutgers, E. J. / Elkhuizen, P. H. et al. | 2009
- S90
-
Breast conservation and sentinel lymph node biopsy after neoadjuvant systemic therapyVeronesi, P. / Gentilini, O. / Fernandez, J. R. / Magnoni, F. et al. | 2009
- S93
-
Should the use of contralateral prophylactic mastectomy be increasing as it is?Wood, W. C. et al. | 2009
- S98
-
Integrated breast conservation and intraoperative radiation therapyOrecchia, R. / Ivaldi, G. B. / Leonardi, M. C. et al. | 2009
- S103
-
Innovations in radiation therapy (RT) for breast cancerLee, L. J. / Harris, J. R. et al. | 2009
- S112
-
Radiotherapy of the regional lymph nodes: shooting at the sheriff?Kunkler, I. H. et al. | 2009
- S122
-
Adjuvant endocrine therapy for premenopausal women with breast cancerPuhalla, S. / Brufsky, A. / Davidson, N. et al. | 2009
- S131
-
Is there a standard type and duration of adjuvant chemotherapy for early stage breast cancer?Hayes, D. F. et al. | 2009
- S135
-
Late effects of adjuvant systemic therapies in women diagnosed with breast cancer at a young ageBurstein, H. J. et al. | 2009
- S137
-
Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant settingColleoni, M. / Viale, G. / Goldhirsch, A. et al. | 2009
- S141
-
Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assaysAlbain, K. S. / Paik, S. / vant Veer, L. et al. | 2009
- S146
-
Targeting HER2 in the adjuvant setting: Dealing with new standards and with open questionsSmith, I. E. et al. | 2009
-
Program Overview| 2009
-
0026 Bioptical method: A major predictor of adherence after benign breast biopsy?Zagouri, F. / Sergentanis, T. N. / Giannakopoulou, G. / Panou, M. / Flessas, J. / Chrisikos, D. / Domeyer, P. / Zografos, G. C. et al. | 2009
-
0075 Use of the genomic test MammaPrint in daily clinical practice to assist in risk stratification of young breast cancer patientsKunz, G. / Glas, A. / de Snoo, F. / Simon, I. et al. | 2009
-
0115 Intraoperative radiotherapy in early breast cancer - preliminary experienceSteiner, M. / Rubinov, R. / Goldman, J. / Cederbaum, M. / Front, A. / Zeevi, P. / Kremer, A. / Salit, Y. / Biterman, A. / Shiloni, E. et al. | 2009
-
0137 Aromatase inhibitors: Questions remaining to be answeredMonnier, A. M. et al. | 2009
-
0141 Combination of antagonists of growth hormone-releasing hormone with docetaxel as potential therapy in breast cancer in a preclinical studySeitz, S. / Schally, A. V. / Papadia, A. / Rick, F. G. / Szlatonay, L. / Ortmann, O. / Engel, J. / Koster, F. / Buchholz, S. et al. | 2009
-
0198 Morbidities after local/regional treatment of breast cancer and patients quality of lifeOzcinar, B. / Guler, S. A. / Ozmen, V. / Gulluoglu, B. M. / Kocaman, N. / Ozkan, M. / Sen Oran, E. / Saricam, G. / Muslumanoglu, M. E. / Igci, A. et al. | 2009
-
S25 Update of the HERA trial and the role of 1 year Trastuzumab as adjuvant therapy for breast cancerGianni, L. / Goldhirsch, A. / Gelber, R. D. / Azambuja, E. / Procter, M. / Untch, M. / Smith, I. / Jackisch, C. / Cameron, D. / Muehlbauer, S. et al. | 2009
-
S36 Lessons on responsiveness to adjuvant systemic therapies learned from the neoadjuvant settingColleoni, M. et al. | 2009
-
S40 Should genomic profiles be used to determine who should receive adjuvant chemotherapy?Albain, K. S. et al. | 2009
-
S42 Adjuvant therapy of triple negative breast cancerPerez, E. A. et al. | 2009
-
0007 Importance of estrogen metabolites (2-OH/16a-OH) in the pathogenesis of breast, ovarian and endometrial cancer in postmenopausal womenAntonova, I. B. / Ashrafyan, L. A. / Basova, I. O. et al. | 2009
-
0014 Antitumor effect of experimental soybean feeding depends on estrogen-sensitivity of tumorsZaletok, S. P. / Samoylenko, E. A. et al. | 2009
-
0023 The analysis of residual lesion after excision of breast lesion using ultrasound-guided vacuum-assisted biopsy device (Mammotome)Kim, S. / Gwak, G. / Kim, K. et al. | 2009
-
0024 How does the method of diagnosis influence the margin status of resection in breast conserving surgery of ductal carcinomas?Sancho Perez, B. / Gallego, M. / Noguero, R. / Sanz, C. / Arroyo, L. / Aragon, S. / Carrascal, A. / De Matias, M. / Blanco, M. / Hernandez, J. M. et al. | 2009
-
0034 Chemopreventive effect of green tea extract and tamoxifen on mouse mammary preneoplastic lesionsSakata, M. / Ikeda, T. / Imoto, S. / Jinno, H. / Kitagawa, Y. et al. | 2009
-
0035 Synchrotron x-ray diffraction of human hair for the early detection of breast pathologies - preliminary resultsPolizzi, S. / Panarisi, P. / Caruso, G. / Corino, G. / French, P. et al. | 2009
-
0094 Breast cancer prediction models for non sentinel axillary lymph node metastases - assessing validity and correlation to disease recurrenceBaruch, E. / Yaal-Hahoshen, N. / Stadler, Y. / Kahn, P. / Gat, A. / Sperber, F. / Even-Sapir, E. / Skornick, Y. / Inbar, M. / Schneebaum, S. et al. | 2009
-
0106 The management of the contralateral breast in breast reconstruction in Korean femalesJung, J. / Lee, J. / Park, H. / Yang, J. / Kim, S. / Lee, Y. et al. | 2009
-
0112 Prone versus supine breast irradiation in early stage breast cancer patientsTrela, K. / Eberhardt, B. / Bereza, I. / Misztal, L. / Gabrys, D. et al. | 2009
-
0154 TEACH: Phase III study of lapatinib after completion of adjuvant chemotherapy in trastuzumab-naive women with HER2-positive breast cancerMoy, B. / Maltzman, J. D. / Rappold, E. / Nicolodi, L. / Williams, L. S. / Goss, P. E. et al. | 2009
-
0158 Multicenter prospective study of bone effects on anastrozole in Japanese postmenopausal patients with breast cancer - results of one year follow-up (SBCCSG 06;UMIN 514)Futsuhara, K. / Tabei, T. / Kojima, M. / Yoshida, T. / Takei, H. / Nakano, S. / Inoue, K. / Takeuchi, H. / Miyake, H. / Kimizuka, K. et al. | 2009
-
0224 Cystic hypersecretory carcinoma of the breastKajo, K. / Zubor, P. / Galo, S. / Klobusiakova, D. / Mazurova, D. et al. | 2009
-
0202 Fatigue in early breast cancer patients receiving adjuvant postoperative chemotherapyHeras, P. / Hatzopoulos, A. / Kritikos, K. / Kapouralos, A. / Androutsos, N. et al. | 2009
-
0212 Triple negative breast cancer - a retrospective analysisShklar, Z. / Steiner, M. / Rabkin, A. / Sinatzky, K. / Rubnov, R. / Leviov, M. / Keren, S. et al. | 2009
-
0234 Impact of education level on clinical characteristics of breast cancer at diagnosis in ChinaGao, J. / Lian, R. / Liang, X. / Wang, G. et al. | 2009
-
0244 A quality initiative: Guideline compliance in postmenopausal women with stage IB-IIIC early breast cancer receiving adjuvant hormonal therapyBosserman, L. / Vanderpool, T. / Bassi, N. / Emilio, B. / Borham, A. / Wang, J. / Chen, C. et al. | 2009
-
S9 Current knowledge on genetic predispositions for breast cancerBrody, L. C. et al. | 2009
-
S18 Pharmacogenetics to drive breast cancer treatmentsMcLeod, H. L. et al. | 2009
-
0003 Detection of methylation in the CpG islands of the RASSF1A gene promoter in breast cancer (BC)Desiris, K. A. / Voyatzi, S. / Stravoravdi, P. / Kiziridou, A. / Paikos, D. / Tremmas, I. / Stergiou, E. / Simbilidis, G. et al. | 2009
-
0002 Adiponectin differentially affects gene expression in human mammary epithelial cells and breast cancer cellsLattrich, C. R. / Treeck, O. / Ortmann, O. et al. | 2009
-
0029 The effects of preoperative 18F-FDG-PET/CT in breast cancer patients in comparison with conventional imaging studyChoi, Y. / Kang, Y. / Nam, S. / Yang, J. et al. | 2009
-
0049 aB crystallin as a novel marker of lymph node metastasis in breast cancerKim, L. / Eom, T. / Kang, H. / Jeon, C. et al. | 2009
-
0060 Circulating tumor cells in early breast cancer - multimarker analysisde Albuquerque, A. / Fersis, N. / Sisic, L. / Kaul, S. et al. | 2009
-
0064 CYP2D6 pharmacogenetics stratifies tamoxifen treatment outcomeSchroth, W. / Goetz, M. P. / Hamann, U. / Fasching, P. A. / Schmidt, M. / Winter, S. / Fritz, P. / Suman, V. J. / Ames, M. M. / Simon, W. et al. | 2009
-
0070 Hormone receptors and HER2 status can change in recurrent breast cancerEppenberger-Castori, S. / Morant, R. / Wight, E. / Vuaroqueaux, V. / Zanetti-Dallenbach, R. / Gueth, U. / Dieterich, H. / Eppenberger, U. et al. | 2009
-
0095 Significance of non-SLN removed simultaneously in SLNB for patients with breast cancerKubo, M. / Shirahane, K. / Kuroki, S. / Tanaka, M. et al. | 2009
-
0097 Is skin-sparing mastectomy oncologically safe also in T3 breast cancer?Lim, W. / Park, E. / Ko, B. / Seo, J. / Kim, H. / Son, B. / Ahn, S. et al. | 2009
-
0108 Early result: Volume replacement with Polyglatin910 mesh for breast reconstruction after endoscopic breast conservative surgery of early breast cancerShin, H. / Lee, J. / Park, H. / Moon, B. et al. | 2009
-
0119 Breast seroma after intraoperative radiotherapy with low-kV x-raysKraus-Tiefenbacher, U. / Welzel, G. / Hermann, B. / Siebenlist, K. / Wasser, K. / Sutterlin, M. / Wenz, F. et al. | 2009
-
0134 CARIATIDE study: Evaluation of the impact of educational material on the compliance and persistence rates to adjuvant aromatase inhibitor (AI) medication for postmenopausal women with hormone sensitive early breast cancerNeven, P. / Serin, D. / Separovic, R. / Ozaslan, C. / Tanner, M. et al. | 2009
-
0210 Retrospective analysis of clinico-pathological trends of triple negative breast cancer: Experience from a tertiary care center of South IndiaJain, A. / Lakshmaiah, K. / Sajeevan, K. / Singh Sateesh, T. / Rao, P. / Mukherjee, G. et al. | 2009
-
Scientific Program Thursday, 12 March 2009| 2009
-
S14 Modulation of angiogenesis: Clinical impact (in breast cancer)Kerbel, R. S. et al. | 2009
-
S33 Radiotherapy of the regional lymph nodes: Shooting at the sheriff?Kunkler, I. et al. | 2009
-
0005 Epigallocatechin-3-gallate decreases VASP expression and MCF-7 cells invasion by inhibiting Rac1 activityZhang, Y. / Han, G. / Fan, B. / Wei, L. et al. | 2009
-
0015 PA-MSHA inhibits proliferation and induces apoptosis through the up-regulation and activation of caspases in the human breast cancer cell linesLiu, Z. / Hou, Y. / Dong, M. / Di, G. / Wu, J. / Shen, Z. / Shao, Z. et al. | 2009
-
0020 Comparison of cytologic findings of nipple discharge with galactographic findingsMatkovic, V. / Hajredini, A. A. / Lide Skalec, S. S. / Mahovlic, V. V. / Ovanin, A. A. / Skopljanec, L. L. / Stepanic, V. V. et al. | 2009
-
0025 A comparative study of immunohistochemical staining and fluorescence in situ hybridization method of HER-2/neu in breast cancerKoo, M. / Moon, B. / Choi, K. / Yom, C. / Park, Y. et al. | 2009
-
0048 Prognostic value of gene expression of ASAH1, LASS4 and LASS6 in breast cancerRuckhaberle, E. / Holtrich, U. / Engels, K. / Hanker, L. / Gaetje, R. / Metzler, D. / Karn, T. / Rody, A. / Kaufmann, M. et al. | 2009
-
0074 Early prognosis prediction: MammaPrint on core-needle biopsiesde Snoo, F. / Glas, A. / Floore, A. / Mayordomo, J. / Modollel, A. / Rolfo, C. / van t Veer, L. / Rutgers, E. / Rodenhuis, S. / Bender, R. et al. | 2009
-
0120 A weekly fractionated radiotherapy regimen for brain metastases in breast cancer patients with poor performance statusMunshi, A. / Trivedi, S. / Budrukkar, A. / Jalali, R. et al. | 2009
-
0178 Results of clinical endpoints of a randomized phase II trial with doxorubicin + pemetrexed followed by docetaxel versus doxorubicin + cyclophosphamide followed by docetaxel as primary systemic therapy for early breast cancerSchneeweiss, A. / Ruiz, A. / Rovira, P. / Bottini, A. / Manikhas, A. / Wacker, J. / Schumacher, T. / Wolf, M. / Segui, M. / Sinn, P. et al. | 2009
-
0227 Profile of in situ carcinoma of the breast in our hospitalCarrascal, A. / Noguero, R. / Sancho, B. / Gallego, M. / Sanz, M. / Arroyo, M. / Aragon, S. / Blanco, M. / De Matias, M. et al. | 2009
-
0230 Multiple primary neoplasms on breast cancer survivorsLukavetskyy, N. et al. | 2009
-
0231 Male patients treated for breast cancer at the institute for oncology and radiology of Serbia in 2001-2002Posarac, V. / Susnjar, S. et al. | 2009
-
0233 The risk of breast cancer among women who start smoking as teenagersOdiase, E. et al. | 2009
-
0240 Variation in early breast cancer adjuvant therapy practice among UK oncologistsMoe, M. M. et al. | 2009
-
Editorial Board| 2009
-
Scientific Program Wednesday, 11 March 2009| 2009
-
S7 EGFR and HER2: Systemic approaches to oncogenic networks and to pharmaceutical perturbationsYarden, Y. et al. | 2009
-
S24 Update of the FINHER trial based on 5 years of follow-upJoensuu, H. / Bono, P. / Kataja, V. / Alanko, T. / Kokko, R. / Asola, R. / Utriainen, T. / Turpeenniemi-Hujanen, T. / Isola, J. / KellokumpuLehtinen, P. et al. | 2009
-
S31 Integrated breast conservation and intraoperative radiation therapy (IORT)Orecchia, R. et al. | 2009
-
0006 Development of novel breast cancer stem cell therapy targeting hedgehog signaling pathwayTanaka, H. / Nakamura, M. / Kubo, M. / Kai, M. / Katano, M. et al. | 2009
-
0032 Breast cancer and sarcoidosis: Case series and review of the literatureChen, J. / Sharon, E. / Maoz, D. / Grief, F. et al. | 2009
-
0040 Correlation between bcl-2 expression and prognostic factors of breast cancerGwak, G. / Park, K. / Han, S. / Park, S. / Cho, H. / Yang, K. / Bae, B. / Kim, K. / Kim, H. / Kim, Y. et al. | 2009
-
0042 EGFR expression and dimerization in the breast cancer resected postoperation tissue can be a negative prognostic factorGarmanchouk, L. V. / Perepelytsina, O. M. / Cheshuk, V. E. / Sydorenko, M. V. et al. | 2009
-
0044 Correlation between histoculture drug response assay (HDRA) and HER2/neu&ER expression in women with breast cancerLee, J. / Kim, S. / Lee, S. / Chun, J. / Lee, H. et al. | 2009
-
0046 Expression of estrogen receptor beta and phosphorylation of estrogen receptor alpha serine 167 correlate with progression-free survival in patients with metastatic breast cancer treated with aromatase inhibitorsMotomura, K. / Ishitobi, M. / Komoike, Y. / Koyama, H. / Nagase, H. / Inaji, H. / Noguchi, S. et al. | 2009
-
0047 Validation of the prognostic impact of Ep-CAM in untreated node-negative breast cancerSchmidt, M. / von Toerne, C. / Boehm, D. / Cotarelo, C. / Lebrecht, A. / Lehr, H. / Koelbl, H. / Gehrmann, M. / Hengstler, J. G. et al. | 2009
-
0058 Determination of ASCO recommended prognostic factors uPA/PAI-1 in clinical routine and the node-negative NNBC 3-Europe therapy trialThomssen, C. / Vetter, M. / Kantelhardt, E. / Geurts-Moespot, A. / Schmidt, M. / Veyret, C. / Meisner, C. / von Minckwitz, G. / Hanf, V. / Martin, P. et al. | 2009
-
0085 Is sentinel lymph node biopsy truly reliable as a single predictor for lymph node metastasis?Ko, B. / Seo, J. / Kim, H. / Lim, W. / Park, E. / Ku, B. / Jang, M. / Son, B. / Ahn, S. et al. | 2009
-
0107 Outcomes of immediate reconstruction with absorbable polypropylene mesh in breast conserving surgery for early breast cancerYom, C. / Park, Y. / Bae, W. / Koo, M. / Moon, B. et al. | 2009
-
0148 REACT study: A phase III multicentre double blind randomised trial of celecoxib versus placebo in primary breast cancer patientsvon Minckwitz, G. / Conrad, B. / Denkert, C. / Eidtmann, H. / Eiermann, W. / Harbeck, W. / Huober, J. / Jackisch, C. / Luck, H. / Mobus, V. et al. | 2009
-
0156 Number needed to treat (NNT) as a drug efficacy measure: Zoledronic acid (ZOL) for early hormone-responsive breast cancer in the ABCSG-12 trialGnant, M. / Mlineritsch, B. / Schippinger, W. / Luschin-Ebengreuth, G. / Steger, G. / Bjelic-Radisic, V. / Jakesz, R. / Kubista, E. / Marth, C. / Greil, R. et al. | 2009
-
0157 GAIN study: A phase III trial to compare ETC vs. EC-TX and ibandronate vs. observation in patients with node-positive primary breast cancervon Minckwitz, G. / Mobus, V. / Conrad, B. / Schneeweiss, A. / Kreienberg, R. / Solomayer, E. / Clemens, M. / Tesch, H. / Loibl, S. / Nekljudova, V. et al. | 2009
-
0174 A phase III study of adjuvant endocrine therapy with or without chemotherapy for postmenopausal breast cancer patients who responded to neoadjuvant letrozole: Study design of the new primary endocrine-therapy origination study [NEOS (N-SAS BC06)]Iwata, H. / Masuda, N. / Toyama, T. / Taira, N. / Yamamoto, Y. / Saji, S. / Kashiwaba, M. / Yamaguchi, T. / Ohashi, Y. et al. | 2009
-
0187 Weekly docetaxel with or without gemcitabine as second line chemotherapy in paclitaxel pretreated patients with metastatic breast cancer: A randomised phase II study conducted by the Hellenic Co-operative oncology groupZagouri, F. / Bamias, A. / Papakostas, P. / Karadimou, A. / Bournakis, E. / Dimopoulos, M. / Fountzilas, G. / Papadimitriou, C. A. et al. | 2009
-
0190 Reseau Romand Fertilite et Cancer (RRFC): Feasibility assessment of a fertility preservation program for young women with early stage breast cancer (EBC)Zaman, K. / Bellavia, M. / Delaloye, J. / Ambrozetti, A. / Petignat, P. / Brioschi, P. / Kohlik, M. / de Candolle, G. / Ifticene Treboux, A. / Wunder-Galie, D. et al. | 2009
-
0193 The impact of type of surgery on quality of life in elderly women with breast cancerNoguero Meseguer, M. / Sanz Ferr andez, M. / Sancho Perez, B. / Gallego Alvarez, M. / De la Cruz, J. / Arroyo Vozmediano, M. / Aragon Sanchez, S. / Blanco Guerrero, M. / Hernandez Garcia, J. et al. | 2009
-
0197 Palonosetron (PALO) plus dexamethasone (DEX) administered on day only prevents emesis and avoids prolonged DEX use in breast cancer patients treated with anthracycline/cyclophosphamide regimensAapro, M. / Misset, J. / Fabi, A. / Steger, G. / Bachmann, C. / Roila, F. / Roncoroni, S. et al. | 2009
-
0213 Clinical characteristics of triple negative breast cancersHur, M. / Yoon, C. / Ko, S. / Lee, H. / Kim, S. / Park, H. / Han, A. / Kang, S. et al. | 2009
-
0218 Breast cancer in the elderly: Does the management of those over 75 years differ from those under 75?Noguero Meseguer, M. / Sanz Ferr andez, M. / Gallego Alvarez, M. / Sancho Perez, B. / Arroyo Vozmediano, M. / Aragon Sanchez, S. / Blanco Guerrero, M. / De Matias, M. / Carrascal Cumplido, A. / Hernandez Garcia, J. et al. | 2009
-
0235 The pattern of breast cancer among patients with the HIV/AIDS virus in Uganda - KampalaMbabazi, M. / Byaruhanga, A. / Byaruhanga, J. et al. | 2009
-
S1 Facilitating consensus by examining patterns of treatment effectsGelber, R. D. et al. | 2009
-
S12 Five year results of a randomised placebo controlled trial of lasofoxifene (PEARL) on the incidence of ER positive breast cancer in postmenopausal women with osteoporosisPowles, T. / Neven, P. / Osborne, C. / Goss, P. / Allred, C. / Cummings, S. / Wolter, K. / Thompson, J. / Armstrong, R. / LaCroix, A. et al. | 2009
-
S16 Immunizing against breast cancer: A new swing for an old swordCurigliano, G. et al. | 2009
-
S20 Combined ER and HER-targeted therapy in breast cancer treatmentOsborne, K. / Schiff, R. et al. | 2009
-
S26 Breast conservation in the very youngRutgers, E. et al. | 2009
-
S35 Adjuvant therapies for premenopausal women with endocrine-responsive diseaseDavidson, N. E. et al. | 2009
-
0001 Thymidylate synthase: Tumor promoter and oncogene in sporadic breast tumorigenesis?Barclay, B. / Murray, D. et al. | 2009
-
0009 Peroxisome proliferator-activated receptor (PPAR)-gamma ligand enhances the growth inhibitory activity of tamoxifen in MCF-7 cellsYoun, H. / Lee, B. / Park, M. / Yoon, J. / Jung, S. et al. | 2009
-
0011 Angiogenesis and lymphangiogenesis are downregulated in primary breast cancerBoneberg, E. M. / Legler, D. F. / Dupont-Lampert, V. / Otto, F. / Senn, H. / Furstenberger, G. et al. | 2009
-
0013 Effect of RNA interference mediated inhibition of VASP expression level on migration and invasion of human mammary epithelial tumor cellsHan, G. / Zhang, Y. / Fan, B. / Wei, L. et al. | 2009
-
0061 Prognostic factors for patients with invasive ductal carcinoma of the breast who received neoadjuvant chemotherapyTamura, N. et al. | 2009
-
0063 Comparison of MammaPrint and TargetPrint results with clinical parameters in German patients (PATH) with early stage breast cancerKunz, G. / Dimpfl, T. / Jakisch, C. / Buttner, R. / de Snoo, F. / Krijgsman, O. / van Lienen, E. / Glas, A. / Bender, R. et al. | 2009
-
0065 Predictive factors for response to fulvestrant - the impact of prior endocrine response on treatment outcomeGradishar, W. / Lindemann, J. et al. | 2009
-
0072 The 70-gene MammaPrint signature for optimal risk stratification in endocrine responsive breast cancerKnauer, M. / Rutgers, E. / Mook, S. / Cardoso, F. / van de Vijver, M. / Viale, G. / Glas, A. / Saghatchian, M. / Kok, M. / Bueno-de-Mesquita, J. et al. | 2009
-
0117 Radiofrequency ablation of early breast cancer followed by delayed surgical resectionOhtani, S. / Higaki, K. / Itoh, M. / Araki, Y. / Takada, S. / Matsuura, H. / Moriya, T. et al. | 2009
-
0139 Why 28% of ER-negative/PR-negative breast cancer (BC) patients did not get chemotherapy (CT)Brouckaert, O. / Van Belle, V. / Berteloot, P. / Amant, F. / Leunen, K. / Van Gorp, T. / Wildiers, H. / Paridaens, R. / Vergote, I. / Neven, P. et al. | 2009
-
0170 Phase II trial of neoadjuvant sequential FEC100 followed by docetaxel, carboplatin and trastuzumab (TCH) for HER-2 over-expressing locally advanced breast cancer (LABC): A multi-centre study from British ColumbiaChia, S. / Bryce, C. / Pansegrau, G. / Macpherson, N. / Ellard, S. / Jepson, D. / Yu, C. / Nuraney, S. / Attwell, A. / Hayes, M. et al. | 2009
-
0160 Dosing of zoledronic acid (ZOL) throughout the treatment continuum in patients (pts) with breast cancer (BC)Hadji, P. / Gnant, M. / Aapro, M. / Lipton, A. / Coleman, R. et al. | 2009
-
0171 Neoadjuvant TAC for locally advanced breast cancer: Correlation between response and biological featuresGiardina, G. P. / Marcon, I. / Vallini, I. / Pinotti, G. / Capella, C. / Chiaravalli, A. et al. | 2009
-
0184 Clinical experience with fulvestrant, pure oestrogen receptor (ER) antagonist with no agonist effects, in pre-treated advanced breast cancer patientsMenjon, S. S. / Garcia, J. J. / Gonzalez, E. E. et al. | 2009
-
0182 Concomitant radio-chemotherapy (RCT) in inflammatory breast cancer (IBC) non responsive to primary chemotherapy (CT)Van Praagh-Doreau, I. / Calvet, L. / Auvray, H. / Le Bouedec, G. / Achard, J. et al. | 2009
-
0195 Multidisciplinary service coordinator and clinical care nurse - an intertwined model of multidisciplinary careMuseth, K. E. et al. | 2009
-
0223 Bilateral breast carcinoma - synchronous and metachronous lesion - a retrospective analysis from a tertiary center in South IndiaSelvan, B. / Nair, A. / John, S. et al. | 2009
-
Scientific Program Saturday, 14 March 2009| 2009
-
S22 The follow-up of women at high risk for breast cancer relapseSmith, I. E. et al. | 2009
-
0021 The discrepancy between results of HER2 receptors in needle biopsy and surgical specimen of breast cancerSikorsky, N. / Leitzin, L. / Shklar, Z. / Rubinov, R. / Shtainer, M. et al. | 2009
-
0050 Expression of ER, p53 and HER-2/neu in medullary carcinoma and infiltrating ductal carcinoma with medullary featureKim, S. / Lee, M. / Woo, H. / Han, S. / Lim, C. / Sohn, D. / Kim, E. et al. | 2009
-
0067 Factors influencing postoperative chemotherapy of elderly breast cancer patientsMa, C. / Shen, Z. / Shao, Z. / Shen, K. et al. | 2009
-
0068 Elevated bone resorption predicts shorter recurrence-free survival (RFS) for bone metastasis in breast cancer (BC)Lipton, A. / Chapman, J. / Demers, L. / Shepherd, L. / Han, L. / Wilson, C. / Pritchard, K. / Leitzel, K. / Ali, S. / Pollak, M. et al. | 2009
-
0083 Intra-operative sentinel node metastasis detection in breast cancer by one-step nucleic acid amplification (OSNA): From validation to routine useKhaddage, A. / Bouteille, C. / Seffert, P. / Peoch, M. et al. | 2009
-
0088 What is the profile of patients with breast cancer undergoing sentinel node biopsy in our hospital?Blanco Guerrero, M. / Noguero Meseguer, M. / Gallego Alvarez, M. / Sanz Ferrandez, M. / Gomez Montes, E. / Sancho Perez, B. / Arroyo Vozmediano, M. / Aragon Sanchez, S. / De Matias, M. / Carrascal Cumplido, A. et al. | 2009
-
0110 Timing of radiotherapy and outcome in patients receiving adjuvant endocrine therapyKarlsson, P. / Cole, B. F. / Colleoni, M. / Roncadin, M. / Chua, B. / Gruber, G. et al. | 2009
-
0142 Feasibility study of fluorouracil/epirubicin/cyclophosphamide (FEC75) followed by docetaxel (DOC) as adjuvant chemotherapy in Japanese patients with node positive breast cancerRai, Y. / Tanaka, M. / Mitsuyama, M. / Uga, T. / Tanaka, S. / Nanba, K. / Furusawa, H. / Murata, K. / Nishimura, R. / Oikawa, T. et al. | 2009
-
0147 Demographic features and prognostic profiles of adjuvant chemotherapy regimens in Chinese breast cancer patientsYin, W. / Lu, J. / Di, G. / Lin, Y. / Zhou, L. / Liu, G. / Wu, J. / Shen, K. / Han, Q. / Shen, Z. et al. | 2009
-
0196 Psychosocial and physical activities in shaping quality of life in breast cancer patients among Indian populationSelvan, B. / Mj, P. / Nair, A. et al. | 2009
-
0232 Male breast cancer in Tripoli/LibyaElhabbash, M. M. / Alwindi, A. M. et al. | 2009
-
S19 Regulation of breast cancer metastasis by endogenous human microRNAsTavazoie, S. et al. | 2009
-
S28 Breast conservation and clear margins: Invasive or in situ involvementMorrow, M. / Wu, S. et al. | 2009
-
0017 Expression of beclin-1 in breast cancerSong, J. / Park, H. / Lim, S. et al. | 2009
-
0043 Expression of a multidrug resistance gene product p170 glycoprotein in neoplastic breast tissuesGennatas, C. / Michalaki, V. / Frangou Plemenou, M. / Gennatas, S. / Tsantopoulos, M. / Kondi-Pafiti, A. et al. | 2009
-
0056 The simplest model for prediction of nonsentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodesKim, K. / Kim, W. / Cho, J. / Park, R. / Han, W. / Noh, D. / Park, H. / Oh, S. / Jung, Y. et al. | 2009
-
0090 Axillary staging of breast cancer with the sentinel lymph node (SLN) procedure in over a thousand patients with early breast cancerPersyn, F. / Van Calster, B. / Leunen, K. / Amant, F. / Smeets, A. / Van Ongeval, C. / Van Steen, A. / Stroobants, S. / Mottaghy, F. / Vergote, I. et al. | 2009
-
0091 Sentinel node biopsy after previous breast surgery: Increasing evidenceBurgoa, L. / Luini, A. / Galimberti, V. / Gatti, G. / Arnone, P. / Vento, A. / Trifiro, G. / Viale, G. / Rotmensz, N. / Rodriguez Fernandez, J. et al. | 2009
-
0093 One step nucleic acid amplification (OSNA) as a diagnostic tool for the detection of lymph node metastases in breast cancer patients: From postoperative performance evaluation to intra-operative routine useSchem, C. / Tiemann, K. / Bauerschlag, D. O. / Carstensen, M. H. / Loning, T. / Roder, C. / Batic, O. / Jonat, W. / Maass, N. et al. | 2009
-
0092 A prospective clinical study for molecular intra-operative detection of lymph node metastasis in breast cancer patients by "one step nucleic acid amplification (OSNA)" in comparison with intensive histological investigationBuglioni, S. / Del Chierico, F. / Conti, S. / Visca, P. / Perri, P. / Di Filippo, F. / Perrone Donnorso, R. / Marandino, F. et al. | 2009
-
0098 The timing of recurrence after the surgery of breast cancerJung, J. / Eun, Y. / Park, H. / Yang, J. / Kim, S. / Lee, Y. et al. | 2009
-
0099 Nipple sparing mastectomy: Nipple-areolar recurrenceSeo, J. / Ko, B. / Park, E. / Lee, W. / Kim, H. / Son, B. / Ahn, S. et al. | 2009
-
0105 Is there a promotion of metastasis by autologeous breast reconstruction in patients with invasive breast cancer?Smeets, A. / Van Calster, K. K. / Wildiers, H. / Lobelle, J. J. / Vandevoort, M. M. / Neven, P. / Paridaens, R. / Christiaens, M. M. et al. | 2009
-
0131 Survival & safety of exemestane versus tamoxifen after 2-3 years tamoxifen treatment: A number needed to treat analysis based on the intergroup exemestane study (IES)Kilburn, L. S. / Mundayat, R. / Bliss, J. M. / Coombes, C. / Chirgwin, J. / Chen, C. / Fallowfield, L. / Wang, Z. et al. | 2009
-
0138 ABCSG-16/SALSA: Prospective, open, randomised, multicentre phase III study to assess extended adjuvant treatment with 2 or 5 years anastrozole in postmenopausal women with endocrine-responsive early breast cancer after 5 years of initial adjuvant endocrine therapyGnant, M. / Mlineritsch, B. / Dubsky, P. / Menzel, C. / Schippinger, W. / Manfreda, D. / Poestlberger, S. / Thaler, J. / Stierer, M. / Kubista, E. et al. | 2009
-
0161 Letrozole vs. tamoxifen as adjuvant endocrine therapy for postmenopausal women with receptor-positive breast cancer. Update of the BIG 1-98 primary core analysisThurlimann, B. et al. | 2009
-
0176 Sentinel lymph node biopsy for patients with breast cancer treated with neoadjuvant chemotherapyShimazu, K. / Tamaki, Y. / Taguchi, T. / Noguchi, S. et al. | 2009
-
0186 Treatment options for locally advanced or metastatic triple negative breast cancer: A survey of current UK practiceKilburn, L. S. / Johnson, L. / Bliss, J. M. / Tutt, A. N. et al. | 2009
-
0214 Triple negative breast cancer: Long-term prognosis and treatment target on molecular biological characteristicsAogi, K. / Takashima, S. / Takabatake, D. / Hara, F. / Ohsumi, S. et al. | 2009
-
0215 Adenexal mass in patients with prior breast carcinomaSamizadeh Nikoy Tabalvandani, Z. / Modarres Gilani, M. / Aghai, M. et al. | 2009
-
0222 Breast cancer in an Asian population: Are there racial differences?Seah, J. / Chong, C. K. / Low, S. C. / Tan, S. M. et al. | 2009
-
0246 The changing fashion of breast cancer therapeutics: Analysis of the clinical trial databaseKwok, S. S. / Tsang, J. W. et al. | 2009
-
S4 Did we learn more about adjuvant chemotherapy? The dark side of data from clinical trialsOakman, C. / Di Leo, A. et al. | 2009
-
S6 Mining the steroid receptor cistrome for novel targets, biomarkers and risk allelesBrown, M. et al. | 2009
-
S11 Implications of inherited predisposition for surveillance, risk reduction and treatmentGarber, J. E. et al. | 2009
-
S38 Late effects of systemic adjuvant therapies in women diagnosed with breast cancer at a young ageBurstein, H. J. et al. | 2009
-
0057 The impact of the ratio of positive nodes to removed nodes on recurrence and overall survival in node positive breast cancer patientsLee, S. / Choi, J. / Lim, H. / Kim, W. / Kim, S. / Lee, J. / Kim, J. / Nam, S. / Yang, J. et al. | 2009
-
0133 A survey of oncologists on the duration of adjuvant aromatase inhibitor therapy - factors that influence treatment decisions in early breast cancerCitron, M. L. / Amakye, D. D. / Chlebowski, R. et al. | 2009
-
0219 Breast cancer in "elderly" womenDe Matias Martinez, M. / Noguero Meseguer, M. / Fraile, B. / Sancho, B. / Gallego, M. / Sanz, C. / Arroyo, M. / Aragon, S. / Carrascal, A. / Blanco, M. et al. | 2009
-
0153 Routine clinical usage of trastuzumab (Herceptin) in the adjuvant treatment of breast cancer in Germany - a prospective registry studyDall, P. / Klausmann, M. / Khandan, F. / Urbanczyk, H. / Schoenegg, W. / Eggert, J. / Prechtl, A. / Hinke, A. / Lerchenmuller, C. et al. | 2009
-
0192 Does the stellate ganglion block reduce severe hot flushes and sleep disturbances in breast cancer patients?Haest, K. / Kumar, A. / Leunen, K. / Smeets, A. / Amant, F. / Wildiers, H. / Paridaens, R. / Van Limbergen, E. / Van den Bogaert, W. / Weltens, C. et al. | 2009
-
0220 Survival in patients with hereditary breast cancerBoroday, N. V. / Datsyuk, I. O. et al. | 2009
-
0226 Report of Cowdens syndrome in patient with PTEN mutationMelbarde-Gorkusa, I. / Irmejs, A. / Miklasevics, E. / Strumfa, I. / Vagule, B. / Grinfelde, I. / Gardovskis, J. / Subatniece, S. / Gardovskis, A. et al. | 2009
-
0245 Analysis of clinical information related to breast cancer from a hospital information system and the generation of a new document for recalling clinical informationHwang, K. / Park, Y. / Kwon, H. / Han, W. / Lee, J. / Ko, E. / Kim, E. / Moon, H. / Yu, J. / Kim, J. et al. | 2009
-
Scientific Program Friday, 13 March 2009| 2009
-
S29 Axillary sentinel lymph node: How low can you go?Galimberti, V. et al. | 2009
-
0010 Tryptase expression correlates to angiogenesis in early breast cancerMininni, M. / Ammendola, M. / Patruno, R. / Lucarelli, N. / Valerio, P. / Gadaleta Caldarola, G. / Catino, A. / De Sarro, G. / Gadaleta, C. / Ranieri, G. et al. | 2009
-
0028 Intraoperative imprint cytology for the evaluation of lumpectomy margins status in patients undergoing conservative surgery for early breast cancerSalemis, N. S. / Tsiambas, E. / Gourgiotis, S. / Emmanouilidou, A. et al. | 2009
-
0051 Serum VEGF-C and serum VEGF-R2 in patients with triple negative breast cancerIosifidou, R. / Galaktidou, G. / Lola, D. / Papanikolaou, A. / Vladika, N. / Patakiouta, F. / Bousoulegas, A. et al. | 2009
-
0069 Prognostic factors upa and PAI-1: Feasibility and validity of determination in clinical routineVetter, M. / Lantzsch, T. / Abraha-Spath, S. / Bauerfeind, U. / Geurts-Moespot, A. / Grosse, R. / Dittmer, J. / Sweep, F. / Schmitt, M. / Harbeck, N. et al. | 2009
-
0136 The number needed to treat to save a life: A comparison between aromatase inhibitorsRugo, H. S. / Dranitsaris, G. / Kaura, S. et al. | 2009
-
0144 Sequential dose-dense 5-fluorouracil, epirubicin and cyclophosphamide followed by docetaxel in patients with breast cancer with 4 or more positive lymph nodesBoy, D. / Murialdo, R. / Angelini, I. / Panariello, M. / Tixi, L. / Sacca, V. / Piccardo, A. / Ballestrero, A. et al. | 2009
-
0152 Dose-dense nab-paclitaxel vs paclitaxel with bevacizumab following adriamycin and cytoxan is safe as adjuvant therapy in patients with early-stage breast cancerPippen, J. / Paul, D. / Richards, D. / Bhar, P. / Iglesias, J. et al. | 2009
-
0216 Testosterone protection: Salivary hormone levels in newly diagnosed breast cancer patientsMarinopoulos, S. / Dimitrakakis, C. / Tsigginou, A. / Ambela, C. / Antsaklis, A. et al. | 2009
-
0229 When do locoregional recurrencies occur and how common is contralateral breast cancer?Sundquist, M. / Arnesson, L. G. / Brudin, L. / Fohlin, H. / Tejler, G. et al. | 2009
-
S2 New hypotheses and opportunities: Endocrine therapiesJordan, C. V. / Kim, H. / Lewis-Wambi, J. et al. | 2009
-
S13 The biological information obtainable from circulating tumor cellsCristofanilli, M. et al. | 2009
-
0033 Effects of 5 years of treatment with lasofoxifene on incidence of breast cancer in older women by baseline estradiol levelsPowles, T. / Neven, P. / Osborne, C. / Goss, P. / Allred, C. / Cummings, S. / Wolter, K. / Thompson, D. / Thompson, J. / Armstrong, R. et al. | 2009
-
0054 Tumor size rather than c-erbB-2 gene amplification significantly influence the disease outcome in postmenopausal steroid receptor-positive breast cancer patients treated with adjuvant tamoxifenSusnjar, S. / Vujasinovic, T. / Abu Rabi, Z. / Gavrilovic, D. / Neskovic-Konstantinovic, Z. / Milovanovic, Z. et al. | 2009
-
0071 The 70-gene MammaPrint profile allows to identify a subgroup of very good-prognostic patients with primary breast cancer and 4-9 positive lymph nodesSaghatchian, M. / Mook, S. / Pruneri, G. / Viale, G. / Glas, A. / Eekhout, I. / Knauer, M. / van t Veer, L. et al. | 2009
-
0080 Sentinel node biopsy in DCIS patients: Is it recommended and in whom?Mentrak, Z. / Piechocki, J. / Towpik, E. / Chmielewski, R. / Nagadowska, M. M. / Sienko, L. / Majewski, T. / Kwiatkowski, W. / Olszewski, W. / Kozlowicz-Grudzinska, I. et al. | 2009
-
0082 Sentinel lymph node biopsy for breast cancer: How many nodes to stop at? Our experience at a tertiary centre in SingaporePang, J. S. / Yong, W. / Wong, C. / Ho, G. / Chan, G. G. et al. | 2009
-
0084 Selective sentinel node plus additional non-sentinel node biopsy based on an FDG-PET/CT scan in early breast cancer patients; single institutional experienceKim, J. / Lee, J. / Choi, B. / Kim, Y. / Lee, C. / Chang, E. / Park, H. et al. | 2009
-
0087 The follow-up results of patients without axillary lymph node dissection after false negative SLN biopsyKo, B. / Seo, J. / Kim, H. / Lim, W. / Park, E. / Ku, B. / Jang, M. / Son, B. / Ahn, S. et al. | 2009
-
0102 Isotope-guided surgery for non-palpable breast cancer in Chinese womenHung, W. K. / Chow, M. P. / Ying, M. W. / Lui, C. Y. / Chan, M. C. / Mak, K. L. et al. | 2009
-
0104 Is surgical excision necessary for benign phyllodes tumor of the breast diagnosed and excised by ultrasound-guided vacuum assisted biopsy device (Mammotome)?Park, H. / Song, J. et al. | 2009
-
0145 First safety data from a randomised phase III trial comparing adjuvant epirubicin-cyclophosphamide docetaxel (EC T) vs ET capecitabine (X) in N+ operable breast cancer (BC)Martin, M. / Lluch, A. / Ruiz-Simon, A. / Ribelles, N. / Ruiz-Borrego, M. / Rodriguez-Lescure, A. / Munoz, M. / Ramos, M. / Gonzalez, S. / Margeli, M. et al. | 2009
-
0150 The severity of chemotherapy-induced neutropenia in association with PTGS-2 gene polymorphism in breast cancer patientsYeo, W. / Suen, J. J. / Ho, W. M. / Mo, F. K. / Chan, S. L. / Lam, K. C. / Poon, A. N. / Tang, N. L. et al. | 2009
-
0155 ICE study: Ibandronate with or without capecitabine in elderly patients with early breast cancerReimer, T. / Nitz, U. / Potenberg, J. / Conrad, B. / Schurer, U. / Just, M. / Eidtmann, H. / Heinrich, G. / Loibl, S. / Nekljudova, V. et al. | 2009
-
0172 Neoadjuvant gemcitabine plus doxorubicin (G+A) versus FAC regimen for locally advanced breast cancer patients (phase III randomized study)El-Zawahry, H. M. / Gaffar, R. M. / Abdel Raouf, H. M. / Fikary, E. A. / Ramadan, H. M. / Ezzat, H. A. et al. | 2009
-
0177 Primary endocrine therapy versus chemotherapy in postmenopausal patients with ER-positive breast cancer: 5-year resultsSemiglazov, V. F. / Dashyan, G. A. / Semiglazov, V. V. / Ziltsova, E. K. / Malodusheva, A. A. / Ivanov, V. G. / Donskih, R. V. / Bozhok, A. A. / Paltuev, R. M. / Berstein, L. M. et al. | 2009
-
0179 Weekly paclitaxel and carboplatin is an effective non-anthracycline regimen in preoperative therapy of breast cancerChen, X. / Chen, C. / Wu, J. / Yang, W. / Nie, X. / Di, G. / Lu, J. / Shao, Z. / Shen, Z. et al. | 2009
-
0181 PROACT: A randomised study comparing anastrozole with tamoxifen as neoadjuvant and adjuvant treatment in postmenopausal women with locally advanced breast cancer - a Japanese subgroup analysisImoto, S. / Takatsuka, Y. / Fujiwara, Y. / Inaji, H. / Ikeda, T. / Cataliotti, L. / Buzdar, A. / Noguchi, S. et al. | 2009
-
0185 High-dose fulvestrant (500 mg): Clinical evidence supporting potentially improved efficacy benefits in hormone receptor-positive (HR+) advanced breast cancer (ABC)Harbeck, N. / Kuter, I. / Amakye, D. / Robertson, J. F. / Ellis, M. J. et al. | 2009
-
0199 The impact of adjuvant chemotherapy on quality of life in women with early breast cancerBulotiene, G. / Ostapenko, V. et al. | 2009
-
S41 Targeting HER2 in the adjuvant setting: Dealing with new standards and open questionsSmith, I. E. et al. | 2009
-
0027 Misdiagnosis for intraoperative touch imprint cytology (TIC) of sentinel lymph node for early-stage invasive breast cancer: What affects the overall accuracy of TIC?Chen, J. / Liu, Z. / Chen, T. / Huang, X. / Cheng, J. / Yang, W. / Xu, W. / Shao, Z. / Shen, Z. / Wu, J. et al. | 2009
-
0031 Diabetic mastopathy - a benign breast condition that mimics breast carcinomaChia, C. S. / Tan, F. / Chan, N. / Jara-Lazaro, A. / Chan, G. et al. | 2009
-
0053 Local recurrence rates after breast conserving surgery according to age, location, ER, PR and HER statusOstapenko, V. / Bruzas, S. / Mudenas, A. / Sabonis, J. / Kurtinaits, J. / Jackevicius, A. / Ostapenko, A. et al. | 2009
-
0055 Analysis of HER-2/neu extracellular domain in serum from breast cancer patients: Correlation with clinicopathologic parameters and prognostic significanceVrbanec, D. / Horvatic-Herceg, G. / Sirotkovic-Skerlev, M. / Kralik, S. / Jelisavec-Cosic, S. / Kovac, Z. / Kulic, A. et al. | 2009
-
0062 Prognostic factors for breast cancer - clinical testing and validation from archival materialJaggi, R. / Popovici, V. / Antonov, J. / Delorenzi, M. / Giobbie-Hurder, A. / Viale, G. / Thurlimann, B. / Altermatt, H. / Aebi, S. et al. | 2009
-
0081 Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinomaPark, E. H. / Kim, H. J. / Lim, W. S. / Seo, J. Y. / Ko, B. S. / Son, B. H. / Ko, B. K. / Ahn, S. et al. | 2009
-
0101 Is BCS always successful?Yoon, C. S. / Kang, W. N. / Ko, S. S. / Hur, M. / Lee, H. K. / Kang, S. S. et al. | 2009
-
0113 Hypofractionated adjuvant radiotherapy for early breast cancer: A prospective randomized studySaha, S. / Gangopadhyay, A. / Basu, A. et al. | 2009
-
0116 Intra-operative radiotherapy for breast cancer in patients where external beam radiation was not possible - results after 3 years of follow-upKeshtgar, M. / Vaidya, J. S. / Keller, A. / Wenz, F. / Corica, T. / Joseph, D. / Stacey, C. / Tobias, J. S. / Williams, N. R. / Baum, M. et al. | 2009
-
0130 Initial adjuvant therapy with anastrozole - early- and late-event data from the arimidex, tamoxifen, alone or in combination (ATAC) trial in the hormone-responsive populationHowell, A. / Forbes, J. / Cuzick, J. et al. | 2009
-
0151 Adjuvant dose-dense adriamycin plus cytoxan followed by dose-dense nab-paclitaxel is safe in women with early-stage breast cancer: A pilot studyPippen, J. / OShaughnessy, J. / Ambro, S. / Krekow, L. / Stokoe, C. / Bhar, P. / Iglesias, J. / Robert, N. et al. | 2009
-
0159 Zoledronic acid protective effect on bone loss in postmenopausal women with early breast cancer switched from tamoxifen to letrozoleSafra, T. / Bernstein Molho, R. / Stephansky, I. / Yaal-Hahoshen, N. / Inbar, M. / Ackerstein, A. / Geffen, D. et al. | 2009
-
0175 The changes of the histologic and biologic markers after neoadjuvant chemotherapy in breast cancerLee, K. M. / Choi, U. J. et al. | 2009
-
0188 Distant recurrence and subsequent mortality in breast cancer patients treated at 5 UK centresDoughty, J. C. / Mansell, J. / Monypenny, I. / Skene, A. / Abram, P. / Carpenter, R. / Gattuso, J. / Wilson, C. / Angerson, W. et al. | 2009
-
0200 The impact of culture, sociological and psychological issues on Muslim breast cancer patients in PakistanBanning, M. / Hassan, M. / Hafeez, H. / Faisal, S. / Zafar, A. et al. | 2009
-
0203 Evaluating the needs of women living with metastatic breast cancer: A global surveyMayer, M. / Hunis, A. / Oratz, R. / Glennon, C. / Spicer, P. / Caplan, E. / Fallowfield, L. et al. | 2009
-
0204 Targets and sources of the psychological help for breast cancer patientsMalova, J. V. et al. | 2009
-
0211 The clinical features and prognosis of triple negative breast cancerIzquierdo Sanz, M. / Alsina Maqueda, A. / Cabero Riera, M. / Fabregas Xaurado, R. / Tresserra Casas, F. / Cusido Gimferrer, M. / Ara Perez, C. / Ubeda Hernandez, A. et al. | 2009
-
0241 Scenarios as a tool for decision making in case of the 70-gene signature for breast cancer patientsRetel, V. P. / Rutgers, E. / van Harten, W. H. et al. | 2009
-
0242 Cost effectiveness analysis of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive breast cancerHashem, T. / Al-Sherbini, M. / Abd El-Bary, N. / Swiha, M. et al. | 2009